A Targeted Treatment for Scleroderma?
(MedPage Today) — A monoclonal antibody that binds to the type 1 interferon-alpha receptor showed an acceptable safety profile in a phase I trial for systemic sclerosis, but efficacy was less clear. …read more
© Copyright Africa Health IT News © 2023
